Synbiotic: Clinical Trials

7 trials of Synbiotic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 not yet recruiting, 1 unknown. 7 Phase 2, 3 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 27Completed 5, Not yet recruiting 1, Unknown 1
Phase 33Completed 2, Unknown 1
Phase 11Not yet recruiting 1

Follow Synbiotic: new trials by email Literature Review of Synbiotic trials Research Report on Synbiotic

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Precision Modulation of Gut Microbiome Enteropathogen Colonization in Critical Illness
Synbiotic, Standard of Care (SOC) - Critical Illness
Phase 1 / Phase 2Not yet recruitingUniversity of Calgary642027-01-012026-09-10
SEPSIS: L. Plantarum Trial
Synbiotic, Probiotic, Placebo - Microbial Colonization, Tolerance
Phase 2CompletedThe Hospital for Sick Children5192022-01-072023-04-13
The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty Liver
synbiotic, Placebo - Non Alcoholic Steatohepatitis
Phase 2 / Phase 3UnknownNational Nutrition and Food Technology Institute422014-08-012015-08-20
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)
Maltodextrin, Synbiotic, Sevelamer - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio692014-04-102020-09-11
Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)
Sevelamer, Synbiotic, Maltodextrin - Insulin Sensitivity
Phase 2CompletedThe University of Texas Health Science Center at San Antonio202014-04-022021-10-15
Effects of Synbiotic Supplementation in Metabolic Syndrome
Synbiotic, Placebo - Metabolic Syndrome
Phase 2 / Phase 3CompletedNational Nutrition and Food Technology Institute382012-04-012013-12-11
The Effects of Synbiotics Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Steatohepatitis
synbiotic, placebo - Non Alcoholic Steatohepatitis
Phase 2 / Phase 3CompletedNational Nutrition and Food Technology Institute542012-03-012013-02-15

Conditions studied

Insulin Resistance (2)  ·  Non-alcoholic Fatty Liver Disease (2)  ·  Communicable Diseases (1)  ·  Critical Illness (1)  ·  Cross Infection (1)  ·  Metabolic Syndrome (1)

Sponsors

National Nutrition and Food Technology Institute (3)  ·  The University of Texas Health Science Center at San Antonio (2)  ·  The Hospital for Sick Children (1)  ·  University of Calgary (1)

Countries

United States (2)  ·  Bangladesh (1)  ·  Canada (1)  ·  Iran (1)

Top investigators

Nicolas Musi, MD. (2)  ·  Azita Hekmatdoost, MD, PhD (1)  ·  Daniel Roth, MD, PhD (1)

Results publications

PMID 24401715, PMID 39992135, PMID 42066676, PMID 42141362